Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy.
Wijetunga AR, Chua TC, Nahm CB, Pavlakis N, Clarke S, Chan DL, Diakos C, Maloney S, Ashrafi-Zadeh A, Kneebone A, Hruby G, Jamieson NB, Gill A, Mittal A, Samra JS.
Wijetunga AR, et al. Among authors: chan dl.
Eur J Surg Oncol. 2021 Oct;47(10):2543-2550. doi: 10.1016/j.ejso.2021.04.005. Epub 2021 Apr 30.
Eur J Surg Oncol. 2021.
PMID: 33952409